Next, both HCC and CRC patients were stratified into two groups: ADAR1-down and ADAR1-up, based on the decreased or increased expression of ADAR1 in tumors compared to their matched NT samples, respectively (Fig. 6e, f, lower panels). The gene discussed is ADAR; the disease is colorectal carcinoma.